Healthy Volunteers Enteral Nutrition Study (HEN)
NCT07426003 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 25
Last updated 2026-08-06
Summary
This research study is being conducted to determine the effects of enteral nutrition on healthy people. Enteral nutrition for the purpose of this study refers to the use of a specially developed formula taken by mouth that provides all essential nutrition either in the absence of food or to supplement the intake of foods. Enteral nutrition can be used for many reasons, such as to gain or lose weight, to treat food allergies, or to reduce inflammation in certain intestinal diseases. We would like to understand the effects of enteral nutrition in the absence of intestinal inflammation.
Conditions
- Enteral Nutrition's Effect on the Gut
Interventions
- DIETARY_SUPPLEMENT
-
Kate Farms Peptide 1.5
Kate Farms Peptide 1.5
- OTHER
-
Crohn's disease exclusion diet
This study will use the components of the Crohn's disease exclusion diet Phase 1 which includes chicken breast, eggs, potatoes, bananas and apples
Sponsors & Collaborators
-
James Lewis
lead OTHER
Principal Investigators
-
James Lewis, MD, MSCE · University of Pennsylvania
Study Design
- Allocation
- RANDOMIZED
- Purpose
- BASIC_SCIENCE
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2026-06-17
- Primary Completion
- 2027-04-30
- Completion
- 2027-05-31
Countries
- United States
Study Locations
More Related Trials
-
Study of the Safety and Tolerability of AXA1665 in Subjects With Mild and Moderate Hepatic Insufficiency
NCT04147936 ·Status: COMPLETED ·Phase: NA
-
Pancreatic Enzyme Supplementation for Celiac Disease
NCT02475369 ·Status: TERMINATED ·Phase: PHASE4
-
Prevention of Parenteral Nutrition-Associated Cholestasis With Cyclic Parenteral Nutrition in Infants
NCT01062815 ·Status: TERMINATED ·Phase: NA
-
Pancrelipase With Nutritional Supplement in Patients at Risk of Malnutrition (EFFORT-ENZO)
NCT06826105 ·Status: RECRUITING ·Phase: NA
-
The 8x5 Diet for Bile Acid Diarrhoea: A Feasibility Randomised Controlled Trial
NCT06259396 ·Status: RECRUITING ·Phase: NA
-
Compassionate Use of Omegaven in the Treatment of Parenteral Nutrition Induced Hepatic Injury
NCT02010034 ·Status: COMPLETED ·Phase: NA
-
Phase I Clinical Study of Chondroitin Sulfate for Treatment of NEC
NCT06547424 ·Status: WITHDRAWN ·Phase: PHASE1
-
The Role of Bacterial Overgrowth and Delayed Intestinal Transit in Hepatic Encephalopathy.
NCT01846806 ·Status: TERMINATED ·Phase: NA
-
The Role of Bacterial Overgrowth and Delayed Intestinal Transit in Hepatic Encephalopathy
NCT00281502 ·Status: UNKNOWN ·Phase: PHASE2
-
Early Enteral Nutrition for Severe Acute Pancreatitis
NCT00995098 ·Status: COMPLETED ·Phase: PHASE4
-
Fecal Microbiota Transplant as Treatment of Hepatic Encephalopathy
NCT03420482 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Functional Sucrase Deficiency in Short Bowel Syndrome Patients With Intestinal Failure
NCT04604275 ·Status: TERMINATED ·Phase: PHASE2
-
Citrulline Challenge Study for Healthy Subjects in the United Kingdom
NCT02772861 ·Status: COMPLETED ·Phase: NA
-
Effects of Carnitine Supplementation on Liver and Muscle
NCT03439917 ·Status: COMPLETED ·Phase: NA
-
Evaluating an Amino Acid Based Medical Food w/ Diarrhea in Carcinoid Syndrome & Other NETs
NCT03722511 ·Status: COMPLETED ·Phase: PHASE2
-
The Effects of Pancreatic Enzyme Supplementation in Critically Ill Patients on Enteral Feeding
NCT05112328 ·Status: RECRUITING ·Phase: NA
-
Investigational Study of Oral Fish Oil in Treating Parenteral Nutrition Associated Liver Disease
NCT01191177 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2
-
Evaluation of the Digestive and Metabolic Utilisation of Dietary Protein in Patients With Chronic Pancreatitis
NCT00957151 ·Status: COMPLETED ·Phase: PHASE4
-
RICE Trial: Rifaximin In Chronic Hepatic Encephalopathy - A Randomized, Controlled Trial
NCT00364689 ·Status: TERMINATED ·Phase: PHASE3
-
Nutritional Assessment Tool and Nutritional Intervention in Childhood Chronic Liver Disease
NCT02715973 ·Status: COMPLETED ·Phase: NA
-
To Assess Efficacy of Nutritional Therapy in Secondary Prophylaxis of Hepatic Encephalopathy Versus Lactulose in Patients With Liver Cirrhosis.
NCT03161106 ·Status: WITHDRAWN ·Phase: NA
-
Pilot Open-Label Trial of Resistant Potato Starch in Patients With Cirrhosis and Overt Hepatic Encephalopathy
NCT06425380 ·Status: RECRUITING ·Phase: NA
-
Effect of Acetyl-L-carnitine on Chronic Pancreatitis
NCT02538146 ·Status: TERMINATED ·Phase: EARLY_PHASE1
-
Quality of Life and Nutritional Improvements in Cirrhotic Patients
NCT01842113 ·Status: TERMINATED ·Phase: PHASE4
-
Experimental Gene Transfer Procedure to Treat Alpha 1-Antitrypsin (AAT) Deficiency
NCT00430768 ·Status: COMPLETED ·Phase: PHASE1